Canoe Financial LP Boosts Holdings in Mettler-Toledo International, Inc. $MTD

Canoe Financial LP grew its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 11.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 58,224 shares of the medical instruments supplier’s stock after purchasing an additional 6,206 shares during the period. Canoe Financial LP owned approximately 0.28% of Mettler-Toledo International worth $68,397,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. WPG Advisers LLC purchased a new stake in shares of Mettler-Toledo International during the first quarter valued at approximately $41,000. Zions Bancorporation National Association UT acquired a new stake in shares of Mettler-Toledo International during the first quarter worth approximately $43,000. Golden State Wealth Management LLC grew its position in shares of Mettler-Toledo International by 583.3% during the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier’s stock worth $48,000 after buying an additional 35 shares in the last quarter. Menard Financial Group LLC acquired a new stake in shares of Mettler-Toledo International during the fourth quarter worth approximately $67,000. Finally, Blue Trust Inc. grew its position in shares of Mettler-Toledo International by 520.0% during the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier’s stock worth $73,000 after buying an additional 52 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Insider Activity

In other news, CFO Shawn Vadala sold 300 shares of the business’s stock in a transaction on Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares of the company’s stock, valued at approximately $6,389,588.55. The trade was a 5.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of the business’s stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the transaction, the director directly owned 283 shares of the company’s stock, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,827 shares of company stock valued at $2,371,208. 1.94% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Citigroup raised their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Thursday, August 21st. Bank of America raised their price target on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a “neutral” rating in a research report on Thursday, June 26th. Robert W. Baird raised their price target on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Evercore ISI decreased their price objective on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating for the company in a report on Monday, August 4th. Finally, Barclays began coverage on shares of Mettler-Toledo International in a report on Tuesday, June 24th. They issued an “overweight” rating and a $1,325.00 price objective for the company. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $1,311.11.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock opened at $1,288.55 on Friday. The company has a market cap of $26.54 billion, a PE ratio of 32.63, a P/E/G ratio of 3.82 and a beta of 1.37. The company has a fifty day moving average price of $1,263.93 and a two-hundred day moving average price of $1,186.15. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,521.01.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, topping analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. During the same quarter in the previous year, the company posted $9.65 earnings per share. The firm’s revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.